Amosulalol;Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-;Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-, (+-)-;Amosulalol USP/EP/BP;Amosulalol, 10 mM in DMSO
Amosulalol is an orally active dual inhibitor of α1/β1-adrenergic receptors; it exhibits antihypertensive activity by inhibiting α1-adrenergic receptors, and reduces heart rate and reflexive increases in plasma renin activity (PRA) in spontaneously hypertensive rats (SHR) through inhibition of β1-adrenergic receptors.